摘要
已有的研究表明石榴汁及提取物对阿尔茨海默病( AD )有神经保护作用,但在动物模型身上的数据有限。在此,我们研究了一个标准的石榴提取物(PE)在中老年AD转基因动物模型( R1.40 )身上对AD病理的影响。月龄为24-30的小鼠连续三周每日饲喂PE(100和200mg / kg)和对照组溶液,并在Morris水迷宫和Y迷宫改进的空间进行长期评价工作记忆功能。在脑组织中测定皮质淀粉样蛋白β前体蛋白(APP)和淀粉状蛋白β( Aβ)的水平,以及其他AD相关的生物标志物。PE没有改善小鼠的认知能力,但改变Aβ42和Aβ40肽水平和比率,有利于降低AD发病机制。进一步的分析表明,这种逆转可能是γ分泌酶的活性修饰的结果,这个酶参与这些Aβ亚型的产生。我们的研究结果证明了一个石榴提取物在老年AD动物模型中的特殊的抗淀粉样蛋白形成的机制。
关键词: 阿尔茨海默病,β淀粉样蛋白,γ分泌,多酚,石榴
Current Alzheimer Research
Title:Pomegranate Extract Modulates Processing of Amyloid-β Precursor Protein in an Aged Alzheimer`s Disease Animal Model
Volume: 11 Issue: 9
Author(s): Aseef H. Ahmed, Gehad M. Subaiea, Aseel Eid, Liya Li, Navindra P. Seeram and Nasser H. Zawia
Affiliation:
关键词: 阿尔茨海默病,β淀粉样蛋白,γ分泌,多酚,石榴
摘要: Accumulating research supports the neuroprotective effects of pomegranate (Punica granatum) juice and extracts against Alzheimer’s disease (AD) but there is limited data available in animal models. Here we investigated the effects of a standardized pomegranate extract (PE) on AD pathology in an aged transgenic AD animal model (R1.40).The mice (age 24-30 months) received either PE (at 100 and 200 mg/kg) or a control solution daily for three weeks, and were evaluated in the Morris water maze and the Y-maze for improvements in spatial long-term and working memory functions. Cortical amyloid-β precursor protein (APP) and amyloid-β (Aβ) levels, along with other relevant biomarkers for AD, were measured in brain tissues. PE did not improve cognitive performance of the mice, but altered levels and ratio of the Aβ42 and Aβ40 peptides which would favor a diminution in AD pathogenesis. Further analysis revealed that this reversal could be the product of the modification of γ-secretase enzyme activity, the enzyme involved in the generation of these Aβ isoforms. Our findings support a specific anti-amyloidogenic mechanism of a pomegranate extract in this aged AD animal model.
Export Options
About this article
Cite this article as:
Ahmed H. Aseef, Subaiea M. Gehad, Eid Aseel, Li Liya, Seeram P. Navindra and Zawia H. Nasser, Pomegranate Extract Modulates Processing of Amyloid-β Precursor Protein in an Aged Alzheimer`s Disease Animal Model, Current Alzheimer Research 2014; 11 (9) . https://dx.doi.org/10.2174/1567205011666141001115348
DOI https://dx.doi.org/10.2174/1567205011666141001115348 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Path from Anti Parkinson Drug Selegiline and Rasagiline to Multifunctional Neuroprotective Anti Alzheimer Drugs Ladostigil and M30
Current Alzheimer Research The Multimodal Treatment of Acromegaly: Current Status and Future Perspectives
Endocrine, Metabolic & Immune Disorders - Drug Targets Regulation of Endothelial Nitric Oxide Synthase in Pathophysiological Conditions
Cardiovascular & Hematological Disorders-Drug Targets Phytochemical Therapies in Vascular Functioning: A Molecular Approach
Current Vascular Pharmacology Inhalational Anesthetic Sevoflurane Rescues Retina Function in Alzheimer’s Disease Transgenic Drosophila
Current Alzheimer Research Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Morphofunctional Aspects of the Blood-Brain Barrier
Current Drug Metabolism Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF Biomarkers
Current Alzheimer Research Indian Spices for Healthy Heart - An Overview
Current Cardiology Reviews PUFA for Prevention and Treatment of Dementia?
Current Pharmaceutical Design Review of Synthesis, Assay, and Prediction of β and γ-secretase Inhibitors
Current Topics in Medicinal Chemistry Extracellular Citrate in Health and Disease
Current Molecular Medicine Depression as is Seen by Molecular Spectroscopy. Phospholipid- Protein Balance in Affective Disorders and Dementia
Current Molecular Medicine Current Limitations in the Treatment of Parkinson’s and Alzheimer’s Diseases: State-of-the-Art and Future Perspective of Polymeric Carriers
Current Medicinal Chemistry Inflammation and Mood Disorders: Proinflammatory Cytokines and the Pathogenesis of Depression
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Scopolamine and Depression: A Role for Muscarinic Antagonism?
CNS & Neurological Disorders - Drug Targets Drug Delivery Systems for Prevention and Treatment of Osteoporotic Fracture
Current Drug Targets Analytic strategies to evaluate the association of time-varying exposures to HIV-related outcomes: Alcohol consumption as an example
Current HIV Research Factors of Rapid Cognitive Decline in Late Onset Alzheimer's Disease
Current Aging Science Therapeutic Opportunities in Alzheimer Disease: One for all or all for One?
Current Medicinal Chemistry